HOOKIPA Pharma Inc. Common Stock (HOOK)

Data is currently not available

Quotes

NEWS & ANALYSIS

HOOK HOOK PRESS RELEASES

HOOK Press Releases

Published
Feb 16, 2021

HOOKIPA Pharma to Participate in Upcoming SVB Leerink Global Healthcare Conference

Published
Feb 16, 2021
Published
Dec 11, 2020

HOOKIPA Pharma Announces Closing of Public Offering of $80.9 Million of Common Stock and Preferred Stock, Including Full Exercise of Underwriters’ Option

Published
Dec 11, 2020
Published
Dec 8, 2020

HOOKIPA Pharma Announces Pricing of Public Offering of Common Stock and Preferred Stock

Published
Dec 8, 2020
Published
Dec 8, 2020

HOOKIPA Pharma Announces Proposed Public Offering of Common Stock and Preferred Stock

Published
Dec 8, 2020
Published
Dec 7, 2020

HOOKIPA Interim Phase 1 Monotherapy Data of HB-201 for the Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity and Favorable Tolerability

Published
Dec 7, 2020
Published
Nov 30, 2020

HOOKIPA Announces Positive Phase 2 Interim Safety, Immunogenicity, and Efficacy Data for its Cytomegalovirus Vaccine Candidate HB-101

Published
Nov 30, 2020
Published
Nov 12, 2020

HOOKIPA Pharma Reports Third Quarter 2020 Financial Results and Provides a Corporate Update

Published
Nov 12, 2020
Published
Nov 11, 2020

HOOKIPA Pharma to Participate in Upcoming Investor Conferences in November

Published
Nov 11, 2020
Published
Nov 3, 2020

HOOKIPA Pharma To Report Third Quarter 2020 Financial Results on November 12, 2020

Published
Nov 3, 2020
Published
Oct 29, 2020

HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-202/HB-201 Alternating Vector Therapy to Treat Human Papillomavirus 16-Positive Cancers

Published
Oct 29, 2020
Published
Oct 19, 2020

HOOKIPA Appoints Prof. Jean-Charles Soria, Director General of the Gustave Roussy Cancer Center in Paris, to its Board of Directors

Published
Oct 19, 2020
Published
Sep 16, 2020

HOOKIPA Pharma’s LCMV-based Immunotherapy for HPV16+ Cancers Demonstrates High Immunogenicity, According to Peer Reviewed Article

Published
Sep 16, 2020
Published
Sep 16, 2020

HOOKIPA Pharma to Present at SVB Leerink’s CybeRx Series Vaccine Forum

Published
Sep 16, 2020
Published
Sep 9, 2020

HOOKIPA Pharma to Present at Upcoming Conferences in September

Published
Sep 9, 2020
Published
Aug 13, 2020

HOOKIPA Pharma Reports Second Quarter 2020 Financial Results and Provides a Corporate Update

Published
Aug 13, 2020
Published
Aug 4, 2020

HOOKIPA Pharma To Report Second Quarter 2020 Financial Results on August 13, 2020

Published
Aug 4, 2020
Published
Aug 3, 2020

HOOKIPA Announces Issuance of US and European Patents

Published
Aug 3, 2020
Published
Jun 22, 2020

HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB‑101

Published
Jun 22, 2020
Published
Jun 19, 2020

HOOKIPA Announces Changes to its Board of Directors – Resignation of Sander van Deventer

Published
Jun 19, 2020
Published
Jun 17, 2020

HOOKIPA Announces FDA Clearance of its IND Application for HB-202/201 Clinical Trial to Treat HPV-Positive Cancers

Published
Jun 17, 2020
Back to HOOK Overview

Related Symbols

GME

Data is currently not available
AAPL

Data is currently not available
TSLA

Data is currently not available
AMC

Data is currently not available